LDL oxidation protection (EU-authorized health claim)
Hydroxytyrosol from olive oil has an EU-authorized health claim (EC No 432/2012) stating that 'olive oil polyphenols contribute to the protection of blood lipids from oxidative stress' at doses of ≥5 mg/day hydroxytyrosol. This regulatory recognition is exceptionally rare for a dietary ingredient, confirming the strong evidence base for hydroxytyrosol's antioxidant cardiovascular protection.
Cardiovascular health and blood pressure support
Olive polyphenols reduce cardiovascular risk through multiple mechanisms: LDL oxidation prevention, endothelial function improvement, mild antihypertensive activity, reduced platelet aggregation, and anti-inflammatory COX-1/2 inhibition (oleocanthal). Clinical studies confirm significant blood pressure reduction and improved cardiovascular biomarkers with olive polyphenol supplementation.
Exceptional antioxidant protection
Hydroxytyrosol has an ORAC (oxygen radical absorbance capacity) value of approximately 68,000 — among the highest measured for any natural compound, far exceeding resveratrol (14,000), vitamin C (3,000), and vitamin E (1,500). This antioxidant potency provides broad cellular protection against oxidative stress relevant to aging, cardiovascular disease, and cancer prevention.
Hydroxytyrosol catechol group free radical scavenging and eNOS activation
The catechol (ortho-dihydroxybenzene) moiety of hydroxytyrosol provides exceptional electron-donating capacity for free radical neutralization through hydrogen atom transfer and single electron transfer mechanisms. Simultaneously, hydroxytyrosol activates the Nrf2/ARE pathway, upregulating endogenous antioxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase) for amplified cellular antioxidant protection. The combined direct scavenging and Nrf2 induction explains hydroxytyrosol's superior antioxidant activity relative to structurally simpler polyphenols.
Multiple randomized, double-blind, placebo-controlled trials examining olive polyphenol (hydroxytyrosol) supplementation effects on LDL oxidation, blood pressure, and cardiovascular biomarkers.
Adults with cardiovascular risk factors. Multiple RCTs.
Olive polyphenol supplementation (≥5 mg/day hydroxytyrosol) significantly reduced LDL oxidation markers, improved endothelial function, reduced blood pressure, and improved HDL cholesterol. Basis for EU-authorized health claim (EC 432/2012). Well-tolerated at all clinical doses.